SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 10-Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

For the quarterly period ended July 31, 2006 

OR

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

For the transition period from              to             

Commission file number 000-29665

EXCELSIOR VENTURE PARTNERS III, LLC

(Exact Name of Registrant as Specified in Its Charter)

DELAWARE	13-4102528
(State or Other Jurisdiction of Incorporation or Organization)	(I.R.S. Employer Identification No.)
225 High Ridge Road, Stamford, CT	06905
(Address of Principal Executive Offices)	(Zip Code)

Registrant’s Telephone Number, Including Area Code (203) 352-4400

Former Name, Former Address and Former Fiscal Year, if Changed Since last Report.

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the Registrant is a large accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large filer in Rule 12b-2 of the Exchange Act. (check one):    Large accelerated filer  ¨    Accelerated file  ¨    Non-accelerated filer  x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY

PROCEEDINGS DURING THE PRECEEDING FIVE YEARS:

Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Section 12,13 or 15(d) of the Securities Exchange Act subsequent to the distribution of securities under a plan confirmed by a court.    Yes  ¨    No  ¨

EXCELSIOR VENTURE PARTNERS III, LLC

Excelsior Venture Partners III, LLC’s (the “Company’s”) prospects, including the prospects of its underlying investments, are subject to certain uncertainties and risks. This Quarterly Report on Form10-Q contains certain forward-looking statements within the meaning of the federal securities laws that also involve substantial uncertainties and risks. The future results of the Company and its underlying investments, may differ materially from its historical results and actual results could differ materially from those projected in forward-looking statements as a result of certain risk factors. Readers should pay particular attention to the considerations described in the section of this report entitled “Management’s Discussion and Analysis of Financial Conditions and Results of Operations.” Readers should also carefully review the risk factors described in the other documents the Company files, or has filed, from time to time with the Securities and Exchange Commission.

	INDEX	PAGE NO.
PART I.	FINANCIAL INFORMATION
Item 1.	Financial Statements.	1
	Portfolio of Investments as of July 31, 2006 and October 31, 2005.	2
	Statements of Assets and Liabilities at July 31, 2006 and October 31, 2005.	9
	Statements of Operations for the nine-month periods ended July 31, 2006 and July 31, 2005.	10
	Statements of Operations for the three-month periods ended July 31, 2006 and July 31, 2005.	11
	Statements of Changes in Net Assets for the nine-month periods ended July 31, 2006 and July 31, 2005.	12
	Statements of Cash Flows for the nine-month periods ended July 31, 2006 and July 31, 2005.	13
	Financial Highlights for the nine-month periods ended July 31, 2006 and July 31, 2005.	14
	Notes to Financial Statements.	15
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.	22
Item 3.	Quantitative and Qualitative Disclosures about Market Risk.	24
Item 4.	Controls and Procedures.	25
PART II.	OTHER INFORMATION
Item 1.	Legal Proceedings.	25
Item 2.	Changes in Securities and Use of Proceeds.	25
Item 3.	Defaults Upon Senior Securities.	25
Item 4.	Submission of Matters to a Vote of Security Holders.	25
Item 5.	Other Information.	25
Item 6.	Exhibits and Reports on Form 8-K.	25

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements.

Excelsior Venture Partners III, LLC

Portfolio of Investments (Unaudited)

	July 31, 2006
PORTFOLIO STRUCTURE	Value		Percent of Net Assets
SHORT-TERM INVESTMENTS:
MONEY MARKET INSTRUMENTS	$	16,242,834	20.71	%
INVESTMENT COMPANIES		1,044,128	1.33	%
PRIVATE COMPANIES		49,536,617	63.14	%
PRIVATE INVESTMENT FUNDS		11,542,936	14.71	%
TOTAL INVESTMENTS		78,366,515	99.89	%
OTHER ASSETS & LIABILITIES (NET)		86,306	0.11	%
NET ASSETS	$	78,452,821	100.00	%
Excelsior Venture Partners III, LLC Portfolio of Investments
	October 31, 2005
PORTFOLIO STRUCTURE	Value		Percent of Net Assets
SHORT-TERM INVESTMENTS:
MONEY MARKET INSTRUMENTS	$	27,485,535	29.44	%
INVESTMENT COMPANIES		1,112,759	1.19	%
PRIVATE COMPANIES		54,964,296	58.88	%
PRIVATE INVESTMENT FUNDS		9,030,493	9.68	%
TOTAL INVESTMENTS		92,593,083	99.19	%
OTHER ASSETS & LIABILITIES (NET)		755,764	0.81	%
NET ASSETS	$	93,348,847	100.00	%

Notes to Financial Statements are an integral part of these Financial Statements.

1

Excelsior Venture Partners III, LLC

Portfolio of Investments July 31, 2006 (Unaudited)

Principal Amount/Shares/ Percent Owned		Acquisition Date ##	Value (Note 1)
MONEY MARKET INSTRUMENTS — 20.71%
$            2,260,000	Federal Home Loan Bank Discount Note 4.95%, 08/01/06		$	2,260,000
1,500,000	First Tennessee Bank Certificate of Deposit 5.28%, 08/07/06			1,500,000
3,000,000	Federal Home Loan Bank Discount Note 5.14%, 08/09/06			2,996,573
4,000,000	Federal Farm Credit Bureau Discount Note 5.14%, 08/10/06			3,994,860
4,000,000	Federal Home Loan Bank Discount Note 5.18%, 08/11/06			3,994,245
1,500,000	UBS Financial Commercial Paper 5.25%, 08/14/06			1,497,156
	TOTAL MONEY MARKET INSTRUMENTS (Cost $16,242,834)			16,242,834
PRIVATE COMPANIES ** — 63.14%
Common Stocks #, @ — 1.23%
Capital Equipment — 0.00%
157,396	MIDAS Vision Systems, Inc.	03/03		—
Enterprise Software — 0.00%
1,000,000	***Cydelity, Inc.	01/04		—
Life Sciences — 0.00%
46,860	Genoptix, Inc.	07/03		—
Optical — 1.22%
1,079,541	OpVista, Inc.	06/06		956,182
Semiconductor — 0.01%
40,026	Silverback Systems, Inc.	04/06		11,420
	TOTAL COMMON STOCKS (Cost $19,190,611)			967,602
Preferred Stocks # — 61.21%
Capital Equipment @ — 0.00%
933,593	MIDAS Vision Systems, Inc., Series A-1	03/03		—
Enterprise Software @ — 24.51%
19,995,000	***Cydelity Inc., Series A	01/04		—
19,702,277	***Cydelity Inc., Series A-1	05/06		3,940,456
25,535,051	***Cydelity Inc., Series A-2	05/06		2,500,009
7,146,701	***LogicLibrary, Inc., Series A	01/02, 12/04,02/05 & 08/05 &03/06		3,267,606
3,080,464	***LogicLibrary, Inc., Series A-1	08/03, 05/04		1,408,450
46,362,656	***Pilot Software Inc., Series A	05/02, 04/03, 06/05		8,110,096
				19,226,617
Life Sciences — 7.16%
1,999,999	Archemix Corporation, Inc., Series A	08/02, 01/03, 11/03		1,999,999
700,000	Archemix Corporation, Inc., Series B	03/04, 09/04, 12/05		700,000
942,481	Genoptix, Inc., Series 1-A@	08/04		950,822
1,403,696	Genoptix, Inc., Series 1-B@	08/04		950,822
620,580	Genoptix, Inc., Series 1-C@	08/04, 01/05		554,178
728,413	Genoptix, Inc., Series 1-D@	05/05		461,815
				5,617,636
Medical Technology @ — 3.09%
4,166,667	Tensys Medical, Inc., Series C	03/02		1,887,160
1,187,500	Tensys Medical, Inc., Series D	05/04		537,840
				2,425,000

Notes to Financial Statements are an integral part of these Financial Statements.

2

Excelsior Venture Partners III, LLC

Portfolio of Investments July 31, 2006 — (continued)

Principal Amount/Shares/ Percent Owned		Acquisition Date ##	Value (Note 1)
Optical @ — 8.23%
956,234	NanoOpto Corporation, Series A-1	10/01, 03/02	$	242,618
3,023,399	NanoOpto Corporation, Series B	09/03, 11/03, 01/04, 07/04		1,286,155
1,682,470	NanoOpto Corporation, Series C	03/05		733,389
1,234,263	NanoOpto Corporation, Series D	05/06		382,622
4,299,481	OpVista, Inc., Series AA	06/06		3,808,179
				6,452,963
Semiconductor @ — 7.87%
7,000,000	Chips & Systems, Inc., Series A	03/04		—
772,503	Silverback Systems, Inc., Series A-2	04/06		4,513,973
559,993	Silverback Systems, Inc., Series B	04/06		1,660,551
				6,174,524
Wireless @ — 10.35%
4,433,333	Ethertronics, Inc., Series B	06/01, 09/02, 07/03, 05/04		6,650,000
980,172	Ethertronics, Inc., Series C	05/05, 10/05		1,470,258
				8,120,258
	TOTAL PREFERRED STOCKS (Cost $60,561,473)			48,016,998
Notes @ — 0.70%
Medical Technology — 0.06 %
$     52,017	Tensys Medical, Inc., 8% Bridge Note	07/06		52,017
Semiconductor — 0.00 %
$1,441,133	Chips & Systems, Inc., 6% Bridge Note March 2005 #	11/04, 01/05, 02/05		—
Wireless — 0.64 %
$   500,000	Ethertronics, Inc., 8% Bridge Note	06/06		500,000
	TOTAL NOTES (Cost $1,993,150)			552,017
Warrants #,@ — 0.00%
Optical — 0.00 %
229,410	NanoOpto Corp. Series C (expiration date 12/09)	12/04		—
Wireless — 0.00%
281,667	Ethertronics, Inc., Series B (expiration date 09/07)	09/02, 07/03, 08/03		—
163,580	Ethertronics, Inc., Series C (expiration date 01/09)	05/05, 10/05		—
	TOTAL WARRANTS (Cost $0)			—
	TOTAL — PRIVATE COMPANIES (Cost $81,745,234)			49,536,617

Notes to Financial Statements are an integral part of these Financial Statements.

3

Excelsior Venture Partners III, LLC

Portfolio of Investments July 31, 2006 — (continued)

Principal Amount/Shares/ Percent Owned			Acquisition Date ##	Value (Note 1)
PRIVATE INVESTMENT FUNDS **, # — 14.71%
0.39	%	Advanced Technology Ventures VII, LP	08/01-07/06	$	1,210,015
1.56	%	Burrill Life Sciences Capital Fund	12/02-06/06		1,337,234
1.35	%	CHL Medical Partners II, LP	01/02-07/06		819,062
1.04	%	CMEA Ventures VI, LP	12/03-06/06		626,902
0.36	%	Morgenthaler Partners VII, L.P.	07/01-06/06		1,695,253
0.58	%	Prospect Venture Partners II, LP	06/01-07/06		1,553,290
0.98	%	Sevin Rosen Fund IX, LP	10/04-06/06		1,240,883
2.36	%	Tallwood II, LP	12/02-05/06		1,506,147
1.70	%	Valhalla Partners, LP	10/03-06/06		1,554,150
		TOTAL — PRIVATE INVESTMENT FUNDS (Cost $12,956,824)			11,542,936
INVESTMENT COMPANIES —1.33%
1,044,128		Dreyfus Government Cash Management Fund Institutional Shares (Cost $1,044,128)			1,044,128
TOTAL INVESTMENTS (Cost $111,989,020) — 99.89%					78,366,515
OTHER ASSETS & LIABILITIES (NET) — 0.11%					86,306
NET ASSETS — 100.00%				$	78,452,821

** Restricted as to public resale. Acquired between June 1, 2001 and July 31, 2006. Total cost of restricted securities at July 31, 2006 aggregated $94,702,058. Total value of restricted securities owned at July 31, 2006 was $61,079,553 or 77.86% of net assets.

# Non-income producing securities.

@ At July 31, 2006 the Company owned 5% or more of the company’s outstanding shares thereby making the company an affiliate as defined by the Investment Company Act of 1940, as amended. Total market value of affiliated securities owned at July 31, 2006 (including investments in controlled affiliates) was $46,836,618.

*** At July 31, 2006 the Company owned 25% or more of the company’s outstanding shares thereby making the company a controlled affiliate as defined by the Investment Company Act of 1940, as amended. Total market value of controlled affiliated securities owned at July 31, 2006 was $19,226,617.

## Disclosure is required for restricted securities only.

Notes to Financial Statements are an integral part of these Financial Statements.

4

Excelsior Venture Partners III, LLC

Portfolio of Investments October 31, 2005

Principal Amount/Shares/ Percent Owned		Acquisition Date ##	Value (Note 1)
MONEY MARKET INSTRUMENTS — 29.44%
$            7,000,000	Federal Farm Credit Bank Discount Note 3.67%, 11/2/05		$	6,999,286
4,000,000	Danske Commercial Paper 3.82%, 11/7/05			3,997,453
7,500,000	Federal Home Loan Bank Discount Note 3.68%, 11/07/05			7,495,400
5,000,000	Federal Home Loan Mortgage Corp. Discount Note 3.72%, 11/08/05			4,996,383
4,000,000	Morgan Stanley Commercial Paper 3.84%, 11/08/05			3,997,013
	TOTAL MONEY MARKET INSTRUMENTS (Cost $27,485,535)			27,485,535
PRIVATE COMPANIES ** — 58.88%
Common Stocks #,@ — 0.00%
Capital Equipment — 0.00%
157,396	MIDAS Vision Systems, Inc.	03/03		—
Enterprise Software – 0.00%
1,000,000	***Cydelity, Inc.	01/04		—
Life Sciences – 0.00%
46,860	Genoptix, Inc.	07/03		—
	TOTAL COMMON STOCKS (Cost $5,247,500)			—
Capital Equipment @ — 0.00%
933,593	MIDAS Vision Systems, Inc., Series A-1	03/03		—
Enterprise Software @ — 13.40%
19,995,000	***Cydelity, Inc., Series A	01/04		—
6,530,581	***LogicLibrary, Inc., Series A	01/02, 12/04, 02/05 & 08/05		2,985,916
3,080,464	***LogicLibrary, Inc., Series A-1	08/03 & 05/04		1,408,450
46,362,656	***Pilot Software Inc., Series A	05/02, 04/03, 06/05		8,110,096
				12,504,462
Life Sciences — 5.76%
1,999,999	Archemix Corporation, Series A	08/02, 01/03, 11/03		1,999,999
466,666	Archemix Corporation, Series B	03/04 & 09/04		466,666
942,481	Genoptix, Inc., Series 1-A @	08/04		950,822
1,403,696	Genoptix, Inc., Series 1-B @	08/04		950,822
620,580	Genoptix, Inc., Series 1-C @	08/04, 01/05		554,178
728,413	Genoptix, Inc., Series 1-D @	05/05		461,815
				5,384,302
Medical Technology @ — 2.60%
4,166,667	Tensys Medical, Inc., Series C	03/02		1,887,160
1,187,500	Tensys Medical, Inc., Series D	05/04		537,840
				2,425,000

Notes to Financial Statements are an integral part of these Financial Statements.

5

Excelsior Venture Partners III, LLC

Portfolio of Investments October 31, 2005 – (continued)

Principal Amount/Shares/ Percent Owned		Acquisition Date ##	Value (Note 1)
PRIVATE COMPANIES ** — (continued)
Preferred Stocks # — (continued)
Optical @ — 18.01%
4,330,504	LightConnect, Inc., Series B	07/01	$	5,000,000
12,292,441	LightConnect, Inc., Series C	12/02		992,000
956,234	NanoOpto Corporation, Series A-1	10/01 & 3/02		1,116,350
3,023,399	NanoOpto Corporation, Series B	09/03, 11/03, 01/04, 07/04		1,286,155
1,682,470	NanoOpto Corporation, Series C	03/05		733,389
5,333,333	OpVista, Inc., Series B	07/01		—
12,671,059	OpVista, Inc., Series C	09/03		5,000,000
10,368,483	OpVista, Inc., Series D	11/04		1,058,000
15,935,224	OpVista, Inc., Series E	05/05, 06/05		1,626,030
				16,811,924

Notes to Financial Statements are an integral part of these Financial Statements.

6

Excelsior Venture Partners III, LLC

Portfolio of Investments October 31, 2005 — (continued)

Principal Amount/Shares/ Percent Owned		Acquisition Date	Value (Note 1)
PRIVATE COMPANIES **, @ — (continued)
Preferred Stocks # — (continued)
Semiconductor @ — 5.09%
7,000,000	Chips & Systems, Inc., Series A	03/04	$	—
2,211,898	Silverback Systems, Inc., Series B-1	03/03 & 09/03		1,415,615
34,364,257	Silverback Systems, Inc., Series C	03/03, 09/03, 04/04		3,333,333
				4,748,948
Wireless @ — 8.70%
4,433,333	Ethertronics, Inc., Series B	06/01, 09/02, 07/03, 05/04		6,650,000
980,172	Ethertronics, Inc., Series C	05/05,10/05		1,470,258
				8,120,258
	TOTAL PREFERRED STOCKS (Cost $65,779,204)			49,994,894
Notes @ — 5.32%
Enterprise Software — 3.21%
$3,000,000	***Cydelity, Inc., 8.00% Bridge Note, March, 2006	12/04, 01/05, 02/05, 03/05, 04/05, 05/05, 07/05		3,000,000
Semiconductor — 2.11%
$1,441,133	Chips & Systems, Inc., 6.00% Bridge Note, March 2005 #	11/04, 01/05, 02/05		—
$1,333,335	Silverback Systems, Inc., 5.00% Bridge Note, January 2006	01/05 & 04/05		1,333,335
$   635,871	Silverback Systems, Inc., 5.00% Bridge Note, July 2006	07/05		635,871
				1,969,206
	TOTAL NOTES (Cost $6,410,339)			4,969,206
Warrants #,@ — 0.00%
Enterprise Software — 0.00%
7,500,000	***Cydelity, Inc. Series A (expiration dates 12/08 and 07/09)	12/04 & 07/05		—
Optical — 0.00%
229,410	NanoOpto Corp. Series C (expiration date 12/09)	12/04		—
Semiconductor — 0.00%
4,173,033	Silverback Systems, Inc. Series C (expiration date 01/12 and 07/12)	01/05, 04/05, 07/05		196
Wireless — 0.00%
281,667	Ethertronics, Inc. Series B (expiration date 09/07)	09/02, 07/03, 08/03		—
163,580	Ethertronics, Inc. Series C (expiration date 01/09)	05/05,10/05		—
	TOTAL WARRANTS (Cost $196)			196
	TOTAL — PRIVATE COMPANIES (Cost $77,437,239)			54,964,296

Notes to Financial Statements are an integral part of these Financial Statements.

7

Excelsior Venture Partners III, LLC

Portfolio of Investments October 31, 2005 — (continued)

Principal Amount/Shares/ Percent Owned			Acquisition Date ##	Value (Note 1)
PRIVATE INVESTMENT FUNDS **, # — 9.68%
0.39	%	Advanced Technology Ventures VII, L.P.	08/01-10/05	$	919,392
1.55	%	Burrill Life Sciences Capital Fund	12/02-10/05		988,026
1.35	%	CHL Medical Partners II, L.P.	01/02-08/05		630,925
1.04	%	CMEA Ventures, L.P.	12/03-10/05		532,630
0.36	%	Morgenthaler Partners VII, L.P.	07/01-08/05		1,505,173
0.57	%	Prospect Ventures Partners II, L.P.	06/01-10/05		1,756,519
0.98	%	Sevin Rosen Fund IX, L.P.	10/04-10/05		705,979
2.36	%	Tallwood II, L.P.	12/02-08/05		1,072,808
1.70	%	Valhalla Partners, L.P.	10/03-10/05		919,041
		TOTAL — PRIVATE INVESTMENT FUNDS (Cost $10,373,375)			9,030,493

Shares
INVESTMENT COMPANIES —1.19%
1,112,759	Dreyfus Government Cash Management Fund Institutional Shares (Cost $1,112,759)		1,112,759
	TOTAL INVESTMENTS (Cost $116,408,908) —99.19%		92,593,083
	OTHER ASSETS & LIABILITIES (NET) — 0.81%		755,764
	NET ASSETS —100.00%	$	93,348,847

** Restricted as to public resale. Acquired between June 1, 2001 and October 31, 2005. Total cost of restricted securities at October 31, 2005 aggregated $87,810,614. Total value of restricted securities owned at October 31, 2005 was $63,994,789 or 68.55% of net assets.

# Non-income producing securities.

@ At October 31, 2005, the Company owned 5% or more of the company’s outstanding voting shares thereby making the company an affiliate as defined by the Investment Company Act of 1940, as amended. Total value of affiliated securities owned at October 31, 2005 (including investments in controlled affiliates) was $52,497,631.

*** At October 31, 2005, the Company owned 25% or more of the company’s outstanding voting shares or a controlling interest thereby making the company a controlled affiliate as defined by the Investment Company Act of 1940, as amended. Total value of controlled affiliated securities owned at October 31, 2005 was $15,504,462.

## Disclosure is required for restricted securities only.

Notes to Financial Statements are an integral part of these Financial Statements.

8

Excelsior Venture Partners III, LLC

Statements of Assets and Liabilities

	July 31, 2006 (Unaudited)			October 31, 2005
ASSETS:
Unaffiliated Issuers at value (Cost $32,943,785 and $41,438,334 respectively)	$	31,529,897		$	40,095,452
Controlled Affiliated Issuers at value (Cost $23,226,617 and $19,504,462 respectively)		19,226,617			15,504,462
Non Controlled Affiliated Issuers at value (Cost $55,818,618 and $55,466,112 respectively)		27,610,001			36,993,169
Investments, at value (Cost $111,989,020 and $116,408,908 respectively) (Note 1)		78,366,515			92,593,083
Cash and cash equivalents (Note 1)		1,222			574,146
Interest receivable		15,099			182,860
Distribution receivable		386,460			600,031
Other receivables		1,945			1,945
Prepaid Insurance		12,294			2,380
Total Assets		78,783,535			93,954,445
LIABILITIES:
Management fees payable (Note 2)		197,744			469,295
Professional fees payable		55,000			64,255
Administration fees payable (Note 2)		54,340			53,861
Board of Managers’ fees payable (Note 2)		12,000			8,000
Other payables		11,630			10,187
Total Liabilities		330,714			605,598
NET ASSETS	$	78,452,821		$	93,348,847
NET ASSETS consist of:
Paid-in capital	$	112,075,326		$	117,164,672
Unrealized depreciation on investments		(33,622,505	)		(23,815,825	)
Total Net Assets	$	78,452,821		$	93,348,847
Units of Membership Interest Outstanding (Unlimited Number of no par value units authorized)		295,210			295,210
NET ASSET VALUE PER UNIT	$	265.75		$	316.21

Notes to Financial Statements are an integral part of these Financial Statements.

9

Excelsior Venture Partners III, LLC

Statements of Operations (Unaudited)

	Nine Months Ended July 31,
	2006			2005
INVESTMENT INCOME:
Interest income from unaffiliated investments	$	792,312		$	708,354
Interest income from affiliated investments		198,447			246,383
Dividend income		28,137			25,799
Total Investment Income		1,018,896			980,536
EXPENSES:
Management fees (Note 2)		1,040,862			1,613,160
Professional fees		196,637			151,887
Administration fees (Note 2)		103,507			103,174
Board of Managers’ fees (Note 2)		68,500			44,877
Insurance Expense		33,117			47,528
Custodian fees		25,401			19,865
Miscellaneous fees		22,150			12,390
Total Expenses		1,490,174			1,992,881
NET INVESTMENT LOSS		(471,278	)		(1,012,345	)
NET REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS: (Note 1)
Net realized (loss)/gain on investments on unaffiliated investments		(6,548	)		1,587,218
Net realized loss on investments on affiliated investments		(4,611,520	)		(3,213,258	)
Net change in unrealized depreciation on investments		(9,806,680	)		(6,326,275	)
NET REALIZED AND UNREALIZED LOSS ON INVESTMENTS		(14,424,748	)		(7,952,315	)
NET DECREASE IN NET ASSETS RESULTING FROM OPERATIONS	$	(14,896,026	)	$	(8,964,660	)

Notes to Financial Statements are an integral part of these Financial Statements.

10

Excelsior Venture Partners III, LLC

Statements of Operations (Unaudited)

	Three Months Ended July 31,
	2006			2005
INVESTMENT INCOME:
Interest income from unaffiliated investments	$	225,022		$	229,897
Interest income from affiliated investments		1,780			137,754
Dividend income		12,821			11,064
Total Investment Income		239,623			378,715
EXPENSES:
Management fees (Note 2)		197,744			485,151
Professional fees		80,246			26,748
Administration fees (Note 2)		38,073			32,400
Board of Managers’ fees (Note 2)		38,747			15,123
Insurance Expense		11,052			15,541
Custodian fees		7,500			10,298
Miscellaneous fees		5,750			4,456
Total Expenses		379,112			589,717
NET INVESTMENT LOSS		(139,489	)		(211,002	)
NET REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS: (Note 1)
Net realized gain on investments on unaffiliated investments		2			—
Net realized gain/(loss) on investments on affiliated investments		(4,627,916	)		3,932,996
Net change in unrealized depreciation on investments		(6,867,910	)		(12,261,394	)
NET REALIZED AND UNREALIZED LOSS ON INVESTMENTS		(11,495,824	)		(8,328,398	)
NET DECREASE IN NET ASSETS RESULTING FROM OPERATIONS	$	(11,635,313	)	$	(8,539,400	)

Notes to Financial Statements are an integral part of these Financial Statements.

11

Excelsior Venture Partners III, LLC

Statements of Changes in Net Assets (Unaudited)

	Nine Months Ended July 31,
	2006			2005
OPERATIONS:
Net investment loss	$	(471,278	)	$	(1,012,345	)
Net realized loss on investments		(4,618,068	)		(1,626,040	)
Net change in unrealized depreciation on investments		(9,806,680	)		(6,326,275	)
Net (decrease) in net assets resulting from operations		(14,896,026	)		(8,964,660	)
DISTRIBUTIONS TO SHAREHOLDERS
Distributions		—			(10,875,536	)
NET (DECREASE) IN NET ASSETS		(14,896,026	)		(19,840,196	)
NET ASSETS:
Beginning of period		93,348,847			116,079,433
End of period	$	78,452,821		$	96,239,237

Notes to Financial Statements are an integral part of these Financial Statements.

12

Excelsior Venture Partners III, LLC

Statements of Cash Flows (Unaudited)

	Nine Months Ended July 31,
	2006			2005
CASH FLOWS FROM OPERATING ACTIVITIES:
Net increase (decrease) in net assets resulting from operations	$	(14,896,026	)	$	(8,964,600	)
Adjustments to reconcile net increase (decrease) in net assets from operations to net cash provided by (used in) operating activities:
Net change in unrealized depreciation on investments		9,806,680			6,326,275
Purchase of investments		(13,712,456	)		(18,753,637	)
Proceeds received from the sale of investments and distributions received from private investment funds		2,202,944			15,927,291
Sale of short-term investments – Net		11,311,332			15,147,341
Net realized loss on investments		4,618,068			1,626,040
(Increase)/Decrease in interest receivable		167,761			(267,682	)
Decrease in other receivable		213,571			172,950
Increase in prepaid insurance		(9,914	)		(14,130	)
Decrease in management fee payable		(271,551	)		(98,418	)
Increase/(Decrease) in Board of Managers’ fees payable		4,000			(63,123	)
Decrease in other expenses payable		(7,333	)		(157,651	)
Net cash provided by/(used in) operating activities		(572,924	)		10,880,596
CASH FLOWS FROM FINANCING ACTIVITIES
Cash Distributions to Unitholders		—			(10,875,536	)
Net Cash Used in Financing Activities		—			(10,875,536	)
Net change in cash		(572,924	)		5,060
Cash at beginning of period		574,146			—
Cash at end of period	$	1,222		$	5,060
SUPPLEMENTAL INFORMATION
Non-cash distributions received from private investment funds	$	—		$	47,971

Notes to Financial Statements are an integral part of these Financial Statements.

13

Excelsior Venture Partners III, LLC

Financial Highlights (Unaudited)

Per Unit Operating Performance: (1)

	Nine Months Ended July 31,
	2006			2005
NET ASSET VALUE, BEGINNING OF PERIOD	$	316.21		$	393.21
INCOME FROM INVESTMENT OPERATIONS:
Net investment loss		(1.60	)		(3.43	)
Net realized and unrealized loss on investment transactions		(48.86	)		(26.94	)
Total from investment operations		(50.46	)		(30.37	)
FINANCING ACTIVITIES
Distribution to Members		—			(36.84	)
NET DECREASE IN NET ASSETS:		(50.46	)		(67.21	)
NET ASSET VALUE, END OF PERIOD	$	265.75		$	326.00
TOTAL NET ASSET VALUE RETURN (3), (4)		(15.96	)%		(8.49	)%
RATIOS AND SUPPLEMENTAL DATA (5)
Net assets, end of period (000’s)	$	78,453		$	96,239
Ratios to average net assets: (2)
Expenses		2.24	%		2.42	%
Net investment loss		(0.71	)%		(1.23	)%
Portfolio Turnover Rate (3)		3.42	%		22.44	%

(1) Selected data for a unit of membership interest outstanding through each period.

(2) Annualized.

(3) Not annualized.

(4) Total net asset value return based on per unit net asset value reflects the effects of changes in net asset value based on the performance of the Company during the period, and assumes dividends and distributions, if any, were reinvested. The Company’s units were issued in a private placement and are not traded. Therefore the market value total investment return is not presented.

(5) Income and expense ratios do not reflect the Company’s proportionate share of net investment income (loss) and expenses, including any performance-based fees, of the Private Investment Funds.

Notes to Financial Statements are an integral part of these Financial Statements.

14

EXCELSIOR VENTURE PARTNERS III, LLC

NOTES TO FINANCIAL STATEMENTS

July 31, 2006 (Unaudited)

Note 1 — Significant Accounting Policies

Excelsior Venture Partners III, LLC (the “Company”) is a non-diversified, closed-end management investment company which has elected to be treated as a business development company or “BDC” under the Investment Company Act of 1940, as amended. The Company was established as a Delaware limited liability company on February 18, 2000. The Company commenced operations on April 5, 2001. The duration of the Company is ten years (subject to two 2-year extensions) from the final subscription closing which occurred on May 11, 2001, at which time the affairs of the Company will be wound up and its assets distributed pro rata to members as soon as is practicable.

As a BDC, the Company must be primarily engaged in the business of furnishing capital and making available managerial assistance to companies that generally do not have ready access to capital through conventional financial channels. The Company’s investment objective is to achieve long-term capital appreciation primarily by investing in domestic venture capital and other private companies and, to a lesser extent, domestic and international private funds, negotiated private investments in public companies and international direct investments that the Investment Adviser (as defined below) believes offer significant long-term capital appreciation potential. Venture capital and private investment companies are companies in which the equity is closely held by company founders, management and/or a limited number of institutional investors. The Company does not have the right to demand that such equity securities be registered.

Costs incurred in connection with the initial offering of units totaled $1,468,218. Each member’s pro rata share of these costs was deducted from his, her or its initial capital contribution.

The following is a summary of the Company’s significant accounting policies. Such policies are in conformity with generally accepted accounting principles for investment companies and are consistently followed in the preparation of the financial statements. Generally accepted accounting principles in the United States require management to make estimates and assumptions that affect the reported amounts and disclosures in the financial statements. Actual results could differ from these estimates.

A. Cash and cash equivalents:

Cash and cash equivalents consist of deposits with banks and highly liquid investments with original maturities of 90 days or less.

B. Investment Valuation:

The Company values portfolio securities quarterly and at such other times as, in the Company’s Board of Managers’ (the “Board” or “Board of Managers”) view, circumstances warrant. Securities for which market quotations are readily available generally will be valued at the last sale price on the date of valuation or, if no sale occurred, at the mean of the latest bid and ask prices; provided that, as to such securities that may have legal, contractual or practical restrictions on transfer, a discount of 10% to 40% from the public market price will be applied. Securities for which no public market exists and other assets will be valued at fair value as determined in good faith by the Investment Adviser or a committee of the Board of Managers or both under the supervision of the Board of Managers pursuant to certain valuation procedures summarized below. Securities having remaining maturities of 60 days or less from the date of purchase are valued at amortized cost.

The value for securities for which no public market exists is difficult to determine. Generally, such investments will be valued on a “going concern” basis without giving effect to any disposition costs. There is a range of values that is reasonable for such investments at any particular time. Initially, direct investments are valued based upon their original cost until developments provide a sufficient basis for use of a valuation other than cost.

15

Upon the occurrence of developments providing a sufficient basis for a change in valuation, direct investments will be valued by the “private market” or “appraisal” methods of valuation. The private market method shall only be used with respect to reliable third party transactions by sophisticated, independent investors. The appraisal method shall be based upon such factors affecting the investee company such as earnings, net worth, reliable private sale prices of the investee company’s securities, the market prices for similar securities of comparable companies, an assessment of the investee company’s future prospects or, if appropriate, liquidation value. The values for the investments referred to in this paragraph will be estimated regularly by the Investment Adviser or a committee of the Board under the supervision of the Board of Managers and, in any event, not less frequently than quarterly. However, there can be no assurance that such value will represent the return that might ultimately be realized by the Company from the investments.

The valuation of the Company’s Private Investment Funds is based upon its pro-rata share of the value of the net assets of the Private Investment Fund as determined by such Private Investment Fund, in accordance with its partnership agreement, constitutional or other documents governing such valuation, on the valuation date. If such valuation with respect to the Company’s investments in Private Investment Funds is not available by reason of timing or other event on the valuation date, or are deemed to be unreliable by the Investment Adviser, the Investment Adviser, under supervision of the Board of Managers, shall determine such value based on its judgment of fair value on the appropriate date, less applicable charges, if any.

At July 31, 2006 and October 31, 2005, market quotations were not readily available for securities valued at $61,079,553 or 77.86% of net assets and $63,994,789 or 68.55% of net assets, respectively. Such securities were valued by the Investment Adviser, under the supervision of the Board of Managers. Because of the inherent uncertainty of valuation, the estimated values may differ significantly from the values that would have been used had a ready market for the securities existed, and the differences could be material.

C. Security transactions and investment income:

Security transactions are recorded on a trade date basis. Realized gains and losses on investments sold are recorded on the basis of identified cost. Interest income, adjusted for amortization of premiums and discounts on fixed income investments, is earned from settlement date and is recorded on the accrual basis. Dividend income is recorded on the ex-dividend date.

D. Income taxes:

Under current law and based on certain assumptions and representations, the Company intends to be treated as a partnership for federal, state and local income tax purposes. By reason of this treatment, the Company will itself not be subject to income tax. Rather, each member, in computing income tax, will include his, her or its allocable share of Company items of income, gain, loss, deduction and expense.

The cost of the Private Investment Funds for federal tax purposes is based on amounts reported to the Company on Schedule K-1 from the Private Investment Funds. As of July 31, 2006 and October 31, 2005, the Company had not received information to determine the tax cost of the Private Investment Funds as of those dates. The cost basis for federal tax purposes of the Company’s other investments at July 31, 2006 was $99,032,196, and those investments had net depreciation on a tax basis at July 31, 2006 of $32,208,617, consisting of gross appreciation of $0 and gross depreciation of $32,208,617. The cost basis for federal tax purposes of the Company’s other investments at October 31, 2005 was $106,035,533 and those investments had net depreciation on a tax basis of $22,472,943 consisting of gross appreciation of $0 and gross depreciation of $22,472,943.

16

Note 2 — Investment Advisory Fee, Administration Fee and Related Party Transactions

UST Advisers, Inc. (“USTA”) which has its principal offices at 225 High Ridge Road, Stamford, Connecticut 06905, is a Delaware corporation and registered investment adviser (the “Investment Adviser”). The Investment Adviser is a wholly-owned subsidiary of United States Trust Company, National Association (“USTC-NA”). USTC-NA is a wholly-owned subsidiary of U. S. Trust Corporation (“U.S. Trust”), a registered bank holding company, which has its principal offices at 114 West 47^th Street, New York, New York 10036-1532, and which is, in turn, a wholly-owned subsidiary of The Charles Schwab Corporation (“Schwab”), which has its principal offices at 120 Kearney Street, San Francisco, California 94108.

Prior to December 16, 2005, U.S. Trust Company, N.A., on behalf of its Asset Management Division served as the investment adviser to the Company (the “former Investment Adviser”) pursuant to an Investment Advisory Agreement (the “Agreement”). Effective December 16, 2005, USTA assumed the duties of the former Investment Adviser.

Under the Agreement for the services provided, the Investment Adviser is entitled to receive a management fee at an annual rate equal to 2.00% of the Company’s end of the quarter net assets through the fifth anniversary of the first closing date of April 5, 2001, and 1.00% of net assets thereafter. Prior to December 16, 2005 and pursuant to a sub-advisory agreement (the “Sub-Advisory Agreement”) among the Company, the former Investment Adviser, and United States Trust Company of New York (“U.S. Trust NY”), U.S. Trust NY served as the investment sub-adviser (the “Investment Sub-Adviser”) to the Company and received an investment management fee from the former Investment Adviser and Investment Adviser. As of July 31, 2006 and October 31, 2005, $197,744 and $469,295 were payable to the Investment Adviser and former Investment Adviser, respectively.

Prior to March 31, 2006, USTA was a wholly owned subsidiary of U.S. Trust Company, N.A. (“UST-NA”) and UST-NA and U.S. Trust NY were wholly-owned subsidiaries of U.S. Trust. Effective March 31, 2006, U.S. Trust NY converted into a national bank named United States Trust Company, National Association (USTC-NA) and UST-NA merged into USTC-NA. USTC-NA is the surviving entity and remains a wholly-owned subsidiary of U.S. Trust.

In addition to the management fee, the Investment Adviser is entitled to allocations and distributions equal to the Incentive Carried Interest. The Incentive Carried Interest is an amount equal to 20% of the excess, if any, of the Company’s cumulative realized capital gains on Direct Investments, over the sum of (a) cumulative realized capital losses on investments of any type (b) cumulative gross unrealized capital depreciation on investments of any type (c) cumulative net expenses. Direct Investments means Company investments in domestic and foreign companies in which the equity is closely held by company founders, management, and/or a limited number of institutional investors and negotiated private investments in public companies. As of July 31, 2006 and July 31, 2005, there was no Incentive Carried Interest earned by the Investment Adviser or the former Investment Adviser.

Pursuant to an Administration, Accounting and Investor Services Agreement, the Company retains PFPC Inc. (“PFPC”), a majority-owned subsidiary of The PNC Financial Services Group, as administrator, accounting and investor services agent. In addition, PFPC Trust Company serves as the Company’s custodian. In consideration for its services, the Company (i) pays PFPC a variable fee between 0.105% and 0.07%, based on average quarterly net assets, payable monthly, subject to a minimum quarterly fee of approximately $30,000, (ii) pays annual fees of approximately $15,000 for taxation services and (iii) reimburses PFPC for out-of-pocket expenses.

Charles Schwab & Co., Inc. (the “Distributor”), the principal subsidiary of Schwab, serves as the Company’s distributor for the offering of units. The Investment Adviser paid the Distributor from its own assets an amount equal to 0.02% of the total of all subscriptions received in the offering. The Investment Adviser or an affiliate will pay the Distributor an on-going fee for the sale of units and the provision of ongoing investor services in an amount equal to the annual rate of 0.45% of the average quarterly net asset value of all outstanding units held by investors introduced to the Company by the Distributor through the fifth anniversary of the final subscription closing date and at the annual rate of 0.22% thereafter, subject to elimination upon all such fees totaling 6.5% of the gross proceeds received by the Company from the offering.

17

Each member of the Board of Managers receives a $10,000 annual retainer and the Chairman of the Board receives an additional $1,000 annual retainer. Also, each member of the Board will receive $2,000 per quarterly meeting attended. In addition, each Board member will receive $500 per quarterly telephonic meeting and $500 for any other telephonic special meeting. For each audit committee meetings attended, Board members will receive $1,500, while the Chairman of the Audit Committee will receive an additional $1,000 retainer. Each member of the Board is reimbursed for expenses incurred for attending meetings. No person who is an officer, manager or employee of U.S. Trust, or its subsidiaries, who serves as an officer, manager or employee of the Company receives any compensation from the Company.

As of July 31, 2006 and October 31, 2005, Excelsior Venture Investors III, LLC had an investment in the Company of $49,804,427 and $59,260,913, respectively. This represents an ownership interest of 63.48% in the Company as of both dates.

On November 23, 2004, the Company engaged Deloitte & Touche LLP (“D&T”) as the Company’s Independent Registered Public Accounting Firm for the fiscal year ended October 31, 2004, replacing Ernst & Young LLP (“E&Y”), the Company’s prior independent public accountants. E&Y was terminated by the Company on October 28, 2004 as a result of concerns regarding its independence at the time of issuance of its report on the Company’s October 31, 2003 financial statements. These concerns are the result of certain real estate consulting services performed by E&Y on a contingent fee basis for Charles Schwab & Co., Inc., an affiliate of the Company’s Investment Adviser.

On December 16, 2004, Schwab entered into an agreement with the Company and other funds managed by the former Investment Adviser whereby Schwab has funded a reserve account to be held by the Investment Adviser or its affiliate. This reserve account was established so that the Company and other funds managed by the Investment Adviser will be able to draw upon it to pay in full all costs incurred related to the termination of E&Y. This agreement was executed in order to ensure that these costs related to the termination of E&Y are not borne by the Company, the other funds managed by the Investment Adviser or their respective shareholders. Schwab is an affiliate of the Company’s Investment Adviser. In consideration of the funding of the reserve account, the Company and the other funds managed by the Investment Adviser subrogated all of their claims, causes of action and rights against E&Y for payment of these expenses to Schwab.

Note 3 — Purchases and Sales of Securities

Excluding short-term investments, the Company’s purchases and sales of securities for the nine-month periods ended July 31, 2006, and July 31, 2005 were as follows:

Nine Month Periods Ended July 31,	Purchases ($)	Proceeds ($)
2006	13,712,456	2,202,944
2005	18,753,637	15,927,291

Note 4 — Commitments

As of July 31, 2006, the Company had outstanding investment commitments totaling $11,143,885.

18

Note 5 — Transactions with Affiliated Companies

An affiliated company is a company in which the Company has ownership of more than 5% of the voting securities. The Company did not receive dividends from affiliated companies during the nine months ended July 31, 2006 and 2005 and the year ended October 31, 2005. Transactions with companies, which are or were affiliates, were as follows:

						For the Nine Months Ended July 31, 2006
Name of Investment	Shares/Principal Amount Held at October 31, 2005	October 31, 2005 Value		Purchases / Conversion Acquisitions		Sales / Conversion Proceeds			Interest Received		Realized Gain (Loss)			Shares/Principal Amount Held at July 31, 2006	July 31, 2006 Value (Note 1)
Controlled Affiliates
Pilot Software Inc., Series A Preferred	46,362,656	$	8,110,096	$	—	$	—		$	—	$	—		46,362,656	$	8,110,096
LogicLibrary, Inc., Series A Preferred	6,530,581		2,985,916		281,690		—			—		—		7,146,701		3,267,606
LogicLibrary, Inc., Series A-1 Preferred	3,080,464		1,408,450		—		—			—		—		3,080,464		1,408,450
Cydelity Inc. Series A Preferred	19,995,000		—		—		—			—		—		19,995,000		—
Cydelity Inc. Series A-1 Preferred	—		—		3,940,456		—			—		—		19,702,277		3,940,456
Cydelity Inc. Series A-2 Preferred	—		—		2,500,009		—			—		—		25,535,051		2,500,009
Cydelity Inc. Common Stock	1,000,000		—		—		—			—		—		1,000,000		—
Cydelity Inc. Series A Warrants	7,500,000		—		—		—			—		—		—		—
Cydelity Inc., Bridge Note, 8%	3,000,000		3,000,000		700,000		(3,700,000	)		116,925		—		—		—
Total Controlled Affiliates		$	15,504,462	$	7,422,155	$	(3,700,000	)	$	116,925	$	—			$	19,226,617
Non-Controlled Affiliates
Chips & Systems, Inc., Series A Preferred	7,000,000		—		—		—			—		—		7,000,000		—
Chips & Systems, Inc. Bridge Note	1,441,133		—		—		—			—		—		1,441,133		—
Ethertronics, Inc., Bridge Note	—		—		500,000		—			5,260		—		500,000		500,000
Ethertronics, Inc., Series B Preferred	4,433,333		6,650,000		—		—			—		—		4,433,333		6,650,000
Ethertronics, Inc., Series B Warrants	281,667		—		—		—			—		—		281,667		—
Ethertronics, Inc., Series C Warrants	163,580		—		—		—			—		—		163,580		—
Ethertronics, Inc., Series C Preferred	980,172		1,470,258		—		—			—		—		980,172		1,470,258
Genoptix, Inc., Series 1-A Preferred	942,481		950,822		—		—			—		—		942,481		950,822
Genoptix, Inc., Series 1-B Preferred	1,403,696		950,822		—		—			—		—		1,403,696		950,822
Genoptix, Inc., Common Stock	46,860		—		—		—			—		—		46,860		—
Genoptix, Inc., Series 1-C Preferred	620,580		544,178		—		—			—		—		620,580		554,178
Genoptix, Inc., Series 1-D Preferred	728,413		461,815		—		—			—		—		728,413		461,815
LightConnect, Inc., Series B Preferred	4,330,504		5,000,000		—		(5,000,000	)		—		(3,854,502	)	—		—
LightConnect, Inc., Series C Preferred	12,292,441		992,000		—		(992,000	)		—		(764,733	)	—		—
MIDAS Vision Systems, Inc., Series A-1 Preferred	933,593		—		—		—			—		—		933,593		—
MIDAS Vision Systems, Inc., Common Stock	157,396		—		—		—			—		—		157,396		—
NanoOpto Corp., Series A-1 Preferred	956,234		1,116,350		—		—			—		—		956,234		242,617
NanoOpto Corp., Series B Preferred	3,023,399		1,286,155		—		—			—		—		3,023,399		1,286,155
NanoOpto Corp., Series C Preferred	1,682,470		733,389		—		—			—		—		1,682,470		733,389
NanoOpto Corp., Series C Warrants	229,410		—		—		—			—		—		229,410		—
NanoOpto Corp., Series D Preferred	—		—		382,622		—			—		—		1,234,263		382,622
OpVista, Inc., Common Stock	—		—		9,184,031		—			—		—		1,079,541		956,182
OpVista, Inc., Series AA Preferred	—		—		3,808,179		—			—		—		4,299,481		3,808,179
OpVista, Inc., Series B Preferred	5,333,333		—		—		(4,000,000	)		—		—		—		—
OpVista, Inc., Series C Preferred	12,671,059		5,000,000		—		(2,500,000	)		—		—		—		—
OpVista, Inc., Series D Preferred	10,368,483		1,058,000		—		(1,058,000	)		—		—		—		—
OpVista, Inc., Series E Preferred	15,935,224		1,626,030		—		(1,626,031	)		—		—		—		—
OpVista, Inc., 8% Bridge Note	—		—		1,727,599		(1,727,599	)		29,944		—		—		—
OpVista, Inc., Warrants	—		—		8,681		(8,681	)		—		(8,681	)	—		—
Silverback Systems, Inc., Common	—		—		4,759,081		—			—		—		40,026		11,420
Silverback Systems, Inc., Series B	—		—		1,500,781		—			—		—		559,992		1,660,552
Silverback Systems, Inc., Series A-2 Preferred	—		—		2,070,310		—			—		—		772,503		4,513,973
Silverback Systems, Inc., Series B-1 Preferred	2,211,898		1,415,615		—		(1,415,615	)		—		—		—		—
Silverback Systems, Inc., Series C Preferred	34,364,257		3,333,333		—		(3,343,467	)		—		—		—		—
Silverback Systems, Inc., 5% Bridge Notes	1,969,206		1,969,206		300,000		(2,269,206	)		—		—		—		—
Silverback Systems, Inc., Series C Warrant	4,173,033		196		—		(196	)		—		(196	)	—		—
Tensys Medical, Inc., Bridge Note	—		—		52,017		—			217		—		52,017		52,017
Tensys Medical, Inc., Series C Preferred	4,166,667		1,887,160		—		—			—		—		4,166,667		1,887,160
Tensys Medical, Inc., Series D Preferred	1,187,500		537,840		—		—			—		—		1,187,500		537,840
Total Non -Controlled Affiliates		$	36,993,169	$	24,293,301	$	(23,940,795	)	$	35,421	$	(4,628,112	)		$	27,610,001

19

						For the Year Ended October 31, 2005
Name of Investment	Shares/Principal Amount Held at October 31, 2004	October 31, 2004 Value		Purchases / Conversion Acquisitions		Sales / Conversion Proceeds			Interest Received		Realized Gain (Loss)			Shares/Principal Amount Held at October 31, 2005	October 31, 2005 Value (Note 1)
Controlled Affiliates
Pilot Software Inc., Series A Preferred	20,000,000	$	4,000,000	$	4,110,096	$	—		$	—	$	—		46,362,656	$	8,110,096
Pilot Software Inc., Bridge Note, 9%	750,000		750,000		1,500,000		(2,250,000	)		101,034		—		—		—
LogicLibrary, Inc., Series A Preferred	4,374,256		2,000,000		985,916		—			—		—		6,530,581		2,985,916
LogicLibrary, Inc., Series A-1 Preferred	3,080,464		1,408,450		—		—			—		—		3,080,464		1,408,450
Cydelity Inc. Series A Preferred	19,995,000		4,000,000		—		—			—		—		19,995,000		—
Cydelity Inc. Common Stock	1,000,000		—		—		—			—		—		1,000,000		—
Cydelity Inc. Series A Warrants	—		—		—		—			—		—		7,500,000		—
Cydelity Inc., Bridge Note, 8%	—		—		3,000,000		—			123,531		—		3,000,000		3,000,000
Total Controlled Affiliates		$	12,158,450	$	9,596,012	$	(2,250,000	)	$	224,565	$	—			$	15,504,462
Non-Controlled Affiliates
Adeza Biomedical Corp., Series 5 Preferred	647,948	$	3,000,000	$	—	$	(6,932,996	)	$	—	$	3,932,996		—	$	—
Cenquest, Inc., Series 2 Preferred	4,425		—		—		—			—		(2,000,000	)	—		—
Chips & Systems, Inc., Series A Preferred	7,000,000		3,500,000		—		—			—		—		7,000,000		—
Chips & Systems, Inc. Bridge Note	—		—		1,441,133		—			4,084		—		1,441,133		—
Ethertronics, Inc., Series B Preferred	4,433,333		6,650,000		—		—			—		—		4,433,333		6,650,000
Ethertronics, Inc., Series B Warrants	281,667		—		—		—			—		—		281,667		—
Ethertronics, Inc., Series C Warrants	—		—		—		—			—		—		163,580		—
Ethertronics, Inc., Bridge Note	—		—		250,000		(250,000	)		3,311		—		—		—
Ethertronics, Inc., Series C Preferred	—		—		1,470,258		—			—		—		980,172		1,470,258
Genoptix, Inc., Series 1-A Preferred	942,481		1,253,500		—		—			—		—		942,481		950,822
Genoptix, Inc., Series 1-B Preferred	1,403,696		1,250,000		—		—			—		—		1,403,696		950,822
Genoptix, Inc., Common Stock	46,860		—		—		—			—		—		46,860		—
Genoptix, Inc., Series 1-C Preferred	310,290		277,089		277,089		—			—		—		620,580		554,178
Genoptix, Inc., Series 1-D Preferred	—		—		461,815		—			—		—		728,413		461,815
LightConnect, Inc., Series B Preferred	4,330,504		5,000,000		—		—			—		—		4,330,504		5,000,000
LightConnect, Inc., Series C Preferred	12,292,441		992,000		—		—			—		—		12,292,441		992,000
MIDAS Vision Systems, Inc., Series A-1 Preferred	933,593		—		—		—			—		—		933,593		—
MIDAS Vision Systems, Inc., Common Stock	157,396		—		—		—			—		—		157,396		—
Monterey Design Systems, Inc., Common Stock	708,955		—		—		—			—		(4,750,000	)	—		—
Monterey Design Systems, Inc., Series 2 Preferred	3,333,333		600,000		—		(781,176	)		—		(2,218,825	)	—		—
NanoOpto Corp., Series A-1 Preferred	956,234		—		—		—			—		—		956,234		1,116,350
NanoOpto Corp., Series B Preferred	3,023,399		1,655,119		—		—			—		—		3,023,399		1,286,155
NanoOpto Corp., Bridge Note	—		—		500,000		(511,288	)		11,288		—		—		—
NanoOpto Corp., Series C Preferred	—		—		—		—			—		—		1,682,470		733,389
NanoOpto Corp., Series C Warrants	—		—		—		—			—		—		229,410		—
OpVista, Inc., Series B Preferred	5,333,333		—		—		—			—		—		5,333,333		—
OpVista, Inc., Series C Preferred	12,671,059		5,000,000		—		—			—		—		12,671,059		5,000,000
OpVista, Inc., Series D Preferred	—		—		1,058,000		—			—		—		10,368,483		1,058,000
OpVista, Inc., Series E Preferred	—		—		1,626,030		—			—		—		15,935,224		1,626,030
Silverback Systems, Inc., Series B-1 Preferred	2,211,898		450,051		—		—			—		—		2,211,898		1,415,615
Silverback Systems, Inc., Series C Preferred	34,364,257		4,298,896		—		—			—		—		34,364,257		3,333,333
Silverback Systems, Inc., 5% Bridge Notes	—		—		1,969,206		—			55,783		—		1,969,206		1,969,206
Silverback Systems, Inc., Series C Warrant	—		—		196		—			—		—		4,173,033		196
Tensys Medical, Inc., Series C Preferred	4,166,667		5,000,000		—		—			—		—		4,166,667		1,887,160
Tensys Medical, Inc., Series D Preferred	1,187,500		1,425,000		—		—			—		—		1,187,500		537,840
Virtual Silicon Technology, Inc., Series C Preferred	3,096,551		5,000,000		—		(607,446	)		—		(4,392,554	)	—		—
Virtual Silicon Technology, Inc., Bridge Note	88,738		88,738		492,862		—			—		(492,862	)	—		—
Total Non -Controlled Affiliates		$	45,440,393	$	9,546,589	$	(9,082,906	)	$	74,466	$	(9,921,245	)		$	36,993,169

20

As of October 31, 2005, Archemix Corporation is no longer considered to be an affiliated company. LogicLibrary, Inc. has also been reclassified from a non-controlled affiliate to a controlled affiliate.

In addition, $191,580 of a receivable for the liquidation of Gyration, Inc. securities (which was a non-controlled affiliate prior to the Company’s disposition of those securities) during the year ended October 31, 2004 was written off as a realized loss during the year ended October 31, 2005.

Note 6 — Pending Litigation

The former Investment Adviser was contacted in September 2003 by the Office of the New York State Attorney General (the “NYAG”), and the Securities and Exchange Commission (the “SEC”) in connection with their investigations of practices in the mutual fund industry identified as “market timing” and “late trading” of mutual fund shares (the “Investigations”). The former Investment Adviser has provided full cooperation with respect to these Investigations and continues to review the facts and circumstances relevant to the Investigations. As disclosed previously, these investigations focused on circumstances in which a small number of parties were permitted to engage in short-term trading of shares of certain mutual funds managed by the former Investment Adviser. The short-term trading activities permitted under these arrangements have been terminated and the former Investment Adviser has strengthened its policies and procedures to deter frequent trading.

The former Investment Adviser, certain of its affiliates and others have also been named in four class action lawsuits and two derivative actions which allege that the former Investment Adviser, certain of its affiliates and others allowed certain parties to engage in illegal and improper mutual fund trading practices, which allegedly caused financial injury to the shareholders of certain mutual funds managed by the former Investment Adviser. Each seeks unspecified monetary damages and related equitable relief.

The class and derivative actions described above were transferred to the United States District Court for the District of Maryland for coordinated and consolidated pre-trial proceedings. In November 2005, the Maryland court dismissed many of the plaintiffs’ claims in both the fund shareholder class action and derivative lawsuits. Several affiliates of the former Investment Adviser and individual defendants have also been dismissed. Plaintiffs’ claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended, and under Section 36(b) and 48(a) of the Investment Company Act of 1940, as amended, however, have not been dismissed. Discovery has commenced with respect to plaintiffs’ remaining claims.

While the ultimate outcome of these matters cannot be predicted with any certainty at this time, based on currently available information and consultation with counsel, the Investment Adviser believes that the pending Investigations and private lawsuits are not likely to materially affect the Investment Adviser’s ability to provide investment management services to the Company. Neither the Investment Adviser nor the Company are a subject of the Investigations nor a party to the lawsuits described above.

21

Note 7 — Guarantees

In the normal course of business, the Company enters into contracts that provide general indemnifications. The Company’s maximum exposure under these agreements is dependent on future claims that may be made against the Company, and therefore cannot be established; however, based on experience, the risk of loss from such claims is considered remote.

Note 8 — New Accounting Pronouncement

In July 2006, the Financial Accounting Standards Board (FASB) issued Interpretation 48, Accounting for Uncertainty in Income Taxes — an interpretation of FASB Statement 109 (FIN 48). FIN 48 clarifies the accounting for income taxes by prescribing the minimum recognition threshold a tax position must meet before being recognized in the financial statements. FIN 48 is effective for fiscal years beginning after December 15, 2006. The Company is in the process of evaluating the effects of the adoption of FIN 48 on the financial statements.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Nine-month and Three-month Periods Ended July 31, 2006 as Compared to the Similar Period in 2005

Realized and Unrealized Gains and Losses from Portfolio Investments

For the nine-month periods ended July 31, 2006 and 2005, the Company had a net realized gain (loss) on security transactions of ($4,618,068) and ($1,626,040), respectively. For the nine-month periods ended July 31, 2006 and 2005, the Company had a net change in unrealized depreciation on investments of ($9,806,680) and ($6,326,275), respectively. The net realized loss for the period ended July 31, 2006 was principally the result of the Company’s sale of LightConnect Inc, a private company investment which resulted in a loss of ($4,619,235).The realized loss for the period ended July 31, 2005 was principally the result of the Company’ sale of Monterey Design Systems during the period and partially offset by the gain on the sale of Adeza Biomedical Corporation common shares during the period. The net change in unrealized depreciation for the period ended July 31, 2006 was principally the result of a decrease in the valuation of Nano Opto Corporation of ($873,732), Silverback Systems, Inc of ($2,134,094) and OpVista Inc of ($6,727,848) all private company investments. The net change in unrealized depreciation for the period ended July 31, 2005 was principally the combination of: i) the sale of Monterey Design Systems which resulted in a decrease in unrealized depreciation of approximately $7,150,000 due to the reclassification from unrealized depreciation to realized loss, ii) the sale of Netlogic Microsystems common shares, a public company investment, which resulted in a decrease in unrealized depreciation of $3,293,078, iii) the sale of Senomyx common shares, a public company investment, which resulted in an increase in unrealized depreciation of $1,476,005, iv) a decrease of $4,941,133 due to the write-down of Chips & Systems, a private company investment, v) a decrease of $1,124,649 due to the write-down of Genoptix, a private company investment, vi) a decrease of $4,000,000 due to the write-down of Cydelity, Inc., and vii) a decrease of $5,000,000 due to the write-down of Virtual Silicon Technology, Inc.

For the three-month periods ended July 31, 2006 and 2005, the Company had a net realized (loss)/gain on security transactions of ($4,627,914) and $3,932,996, respectively. For the three-month periods ended July 31, 2006 and 2005, the Company had a net change in unrealized depreciation on investments of ($6,867,910) and ($12,261,394) respectively. The net realized loss for the period ended July 31, 2006 was principally the result of the Company’s sale of LightConnect Inc, a private company investment which resulted in a loss of ($4,619,235). The realized gain for the period ended July 31, 2005 was principally the result of the Company’s sale of Adeza Biochemical common shares during the period. The net change in unrealized depreciation for the period ended July 31, 2006 was principally the result of a decrease in the valuation of OpVista, Inc. of ($6,727,848), a private company investment. The net change in unrealized depreciation for the period ended July 31, 2005 was principally the combination of: i) the sale of Adeza Biomedical Common shares, which resulted in an increase in unrealized depreciation of $3,196,003, ii) a decrease of $4,000,000 due to the write-down of Cydelity, Inc., and iii) a decrease of $5,000,000 due to the write-down of Virtual Silicon Technology, Inc.

Investment Income and Expenses

For the nine-month period ended July 31, 2006, the Company had investment income of $1,018,896 and operating expenses of $1,490,174, resulting in a net investment loss of ($471,278). In comparison, for the similar period ended July 31, 2005, the Company had investment income of $980,536 and operating expenses of $1,992,881, resulting in a net investment loss of ($1,012,345). The increase in net investment income resulted from the increase in short-term interest income and partially offset by a decrease in interest income from affiliated investments. The Company continues its investment program in venture capital companies and private equity funds. The decrease in operating expenses was due primarily to a decline in management fees as a result of reduced net assets under management during the period and the change of the management fee at an annual rate equal to 2.00% of the Company’s end of the quarter net assets through the fifth anniversary of the first closing date of April 5, 2001, to 1.00% of net assets thereafter.

22

For the three-month period ended 30, 2006, the Company had investment income of $239,623 and net operating expenses of $379,112 resulting in a net investment loss of ($139,489). In comparison, for the similar period ended July 31, 2005, the Company had investment income of $378,715 and net operating expenses of $589,717, resulting in a net investment loss of ($211,002). The decrease in net investment income for the period ended July 31, 2006 resulted from a decrease in investment income from affiliated investments. The decrease in operating expenses was primarily due to a decline in management fees which resulted from a reduced level of net assets under management during the period and the change of the management fee at an annual rate equal to 2.00% to 1.00% of net assets.

The Investment Adviser and the Investment Sub-Adviser, provide investment management and administrative services required for the operation of the Company. In consideration of the services rendered by the Investment Adviser and the Investment Sub-Adviser, the Company pays a management fee based upon a percentage of the net assets of the Company invested or committed to be invested in certain types of investments and an incentive fee based in part on a percentage of realized capital gains of the Company as described in Note 2 to Item 1 above. Such fee is determined and payable quarterly. For the nine-month periods ended July 31, 2006 and 2005, the Investment Adviser, the former Investment Adviser and the Investment Sub-Adviser earned $1,040,862 and $1,613,160 in management fees, respectively. Management fees, recorded during the period ended July 31, 2006 decreased over the period ended July 31, 2005 due to a decrease in net assets and the change of the management fee at an annual rate equal of 2.00% to 1.00% of net assets. For the three-month periods ended July 31, 2006 and 2005, the Investment Advisers earned $197,744 and $485,151 in management fees, respectively. Management fees recorded during the period ended July 31, 2006 decreased over the period ended July 31, 2006 due to a decline in net assets under management and the change of the fees from 2.00% to 1.00% of net assets

Net Assets

At July 31, 2006, the Company’s net assets were $78,452,821, or a net asset value per unit of membership interest of $265.75. This represents a decrease of ($14,896,026) from net assets of $93,348,847, or a net asset value per unit of membership interest of $316.21, at October 31, 2005. The decrease resulted principally from (i) net realized loss on investments of ($4,618,068) as describe above, (ii) a net change in unrealized depreciation on investments of ($9,806,680) as described above, and (iii) net investment loss of ($471,278) as described above.

Liquidity and Capital Resources

The Company will focus its investments in the securities of privately-held venture capital companies, and to a lesser extent in venture capital, buyout and other private equity funds managed by third parties. The Company may offer managerial assistance to certain of such privately-held venture capital companies. The Company invests its available cash in short-term investments of marketable securities pending distribution to investors.

At July 31, 2006, the Company held $1,222 in cash and $17,286,962 in short-term investments as compared to $574,146 held in cash and $28,598,294 in short-term investments at October 31, 2005. The decrease in short-term investments from October 31, 2005 was principally due to new and follow-on investments in private companies as well as capital calls for private investment funds. The Company, during this period, funded additional capital totaling $3,412,461, per its commitments to the private investment funds. In connection with the Company’s total commitments to private funds in the amount of $25,700,000 since inception, the Company, through July 31, 2006, has contributed $14,556,115 or 56.6 % of the total capital committed thus far. The Company also participated in follow-on financing rounds, totaling $9,936,587, for several of its private companies.

The Company believes that its liquidity and capital resources are adequate to satisfy its operational needs as well as the continuation of its investment program.

23

Application of Critical Accounting Policies

Under the supervision of the Company’s Valuation and Audit Committees, consisting of the independent Managers of the Company, the Investment Adviser makes certain critical accounting estimates with respect to the

valuation of private portfolio investments. These estimates could have a material impact on the presentation of the Company’s financial condition because in total, they currently represent 77.86% of the Company’s net assets. For the private investments held at July 31, 2006, changes to these estimates, i.e. changes in the valuations of these private investments, resulted in a $9,806,680 decrease in net asset value from October 31, 2005.

The value for securities for which no public market exists is difficult to determine. Generally speaking, such investments will be valued on a “going concern” basis without giving effect to any disposition costs. There is a range of values that is reasonable for such investments at any particular time. Because of the inherent uncertainty of valuation, the estimated values may differ significantly from the values that would have been used had a ready market for the securities existed, and the differences could be material.

Initially, direct private company investments are valued based upon their original cost until developments provide a sufficient basis for use of a valuation other than cost. Upon the occurrence of developments providing a sufficient basis for a change in valuation, direct private company investments will be valued by the “private market” or “appraisal” methods of valuation. The private market method shall only be used with respect to reliable third party transactions by sophisticated, independent investors. The appraisal method shall be based upon such factors affecting the company such as earnings, net worth, reliable private sale prices of the company’s securities, the market prices for similar securities of comparable companies, an assessment of the company’s future prospects or, if appropriate, liquidation value. The values for the investments referred to in this paragraph will be estimated regularly by the Investment Adviser or a committee of the Board, both under the supervision of the Board, and, in any event, not less frequently than quarterly. However, there can be no assurance that such value will represent the return that might ultimately be realized by the Company from the investments.

The valuation of the Company’s private funds is based upon its pro-rata share of the value of the assets of a private fund as determined by such private fund, in accordance with its partnership agreement, constitutional or other documents governing such valuation, on the valuation date. If such valuation with respect to the Company’s investments in private funds is not available by reason of timing or other event on the valuation date, or are deemed to be unreliable by the Investment Adviser, the Investment Adviser, under supervision of the Board, shall determine such value based on its judgment of fair value on the appropriate date, less applicable charges, if any.

The Investment Adviser also makes estimates regarding discounts on market prices of publicly traded securities where appropriate. For securities which have legal, contractual or practical restrictions on transfer, a discount of 10% to 40% from the public market price will be applied.

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

Equity Price Risk

The Company anticipates that a majority of its investment portfolio will consist of securities in private companies and private investment funds, currently representing 77.86% of net assets, which are not publicly traded. These investments are recorded at fair value as determined by the Investment Adviser in accordance with valuation guidelines adopted by the Board of Managers. This method of valuation does not result in increases or decreases in the fair value of these securities in response to changes in market prices. Thus, these securities are not subject to equity price risk normally associated with public equity markets, except that to the extent that the private investment funds hold underlying public securities, the Company is indirectly exposed to equity price risk associated with the public markets. At July 31, 2006, and October 31, 2005 the Company was not subject to equity price risk normally associated with public equity markets, except to the extent that the private investment funds that the Company has invested in has, from time to time, interests in securities which may be publicly traded.

24

Item 4. Controls and Procedures.

(a) Evaluation of Disclosure Controls and Procedures. As of July 31, 2006 (the end of the period covered by this report), the Company’s principal executive officers and principal financial officer evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in the Securities Exchange Act of 1934 Rules 13a-15(e) and

15d-15(e)) and have concluded that, based on such evaluation, the Company’s disclosure controls and procedures were adequate and effective to ensure that material information relating to the Company was made known to them by others within those entities.

(b) Changes in Internal Controls. There were no changes in the Company’s internal control over financial reporting identified in connection with the evaluation of such internal control that occurred during the Company’s last fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings.

None.

Item 2. Changes in Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Submission of Matters to a Vote of Security Holders.

None.

Item 5. Other Information.

None.

Item 6. Exhibits and Reports on Form 8-K.

(a) Exhibits.

31.1 Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2 Certification of Treasurer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32 Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

(b) Reports on Form 8-K.

On August 3, 2006, the Company filed a Current Report on Form 8-K to report under Item 7.01 certain disclosures.

25

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	EXCELSIOR VENTURE PARTNERS III, LLC
Date: September 14, 2006	By:	/s/ Leo P. Grohowski
		Leo P. Grohowski
		Co-Chief Executive Officer
Date: September 14, 2006	By:	/s/ Raghav V. Nandagopal
		Raghav V. Nandagopal
		Co-Chief Executive Officer
Date: September 14, 2006	By:	/s/ Robert F. Aufenanger
		Robert F. Aufenanger
		Treasurer
		(Principal Financial Officer)

26